ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
101,090.30
1.03%
S&P 500
6,065.72
0.24%
Dow Jones
43,861.65
-0.12%
US Dollar vs Yen
153.608
0.71%
Brent Oil
73.695
0.66%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) ニュース

PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PBYI
日付受信時刻ニュースソース見出しコード企業名
2024/12/0507 : 15Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/11/2022 : 57Business WirePuma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerNASDAQ:PBYIPuma Biotechnology Inc
2024/11/1502 : 12Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
2024/11/0907 : 31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PBYIPuma Biotechnology Inc
2024/11/0806 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/11/0806 : 05Business WirePuma Biotechnology Reports Third Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/11/0607 : 15Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/10/2505 : 07Business WirePuma Biotechnology to Host Conference Call to Discuss Third Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/10/2304 : 24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PBYIPuma Biotechnology Inc
2024/09/1622 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/09/0405 : 15Business WirePuma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:PBYIPuma Biotechnology Inc
2024/08/2806 : 02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PBYIPuma Biotechnology Inc
2024/08/1522 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/08/0722 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/08/0706 : 23Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/08/0205 : 41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBYIPuma Biotechnology Inc
2024/08/0205 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/08/0205 : 05Business WirePuma Biotechnology Reports Second Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1908 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1908 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1907 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1905 : 10Business WirePuma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1809 : 43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1809 : 39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1809 : 36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/0306 : 30Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:PBYI

最近閲覧した銘柄

PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
NYSE
KO
Coca Cola
COIN
AVAXUSD
Avalanche
NYSE
MRK
Merck
AMEX
XLV
Health Care Select Sector
COIN
DOGEUSD
Dogecoin
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
NYSE
XOM
Exxon Mobil
NYSE
CVX
Chevron
SPI
SP500
S&P 500
AMEX
XLF
Financial Select Sector
COIN
BTCUSD
Bitcoin
CCOM
US100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有